Human 20α–Hydroxysteroid Dehydrogenase: Crystallographic and Site-directed Mutagenesis Studies Lead to the Identification of an Alternative Binding Site for C21-steroids

Human 20alpha-hydroxysteroid dehydrogenase (h20alpha-HSD; AKR1C1) catalyzes the transformation of progesterone (Prog) into 20alpha-hydroxy-progesterone (20alpha-OHProg). Although h20alpha-HSD shares 98% sequence identity with human type 3 3alpha-HSD (h3alpha-HSD3, AKR1C2), these two enzymes differ greatly in their activities. In order to explain these differences, we have solved the crystal structure of h20alpha-HSD in a ternary complex with NADP(+) and 20alpha-OHProg at 1.59A resolution. The steroid is stabilized by numerous hydrophobic interactions and a hydrogen bond between its O20 and the N(epsilon ) atom of His222. This new interaction prevents the formation of a hydrogen bond with the cofactor, as seen in h3alpha-HSD3 ternary complexes. By combining structural, direct mutagenesis and kinetic studies, we found that the H(222)I substitution decreases the K(m) value for the cofactor 95-fold. With these results, we hypothesize that the rotation of the lateral chain of His222 could be a mediating step between the transformation of Prog and the release of the cofactor. Moreover, crystal structure analysis and direct mutagenesis experiments lead us to identify a new residue involved in the binding of Prog. Indeed, the R(304)L substitution leads to a 65-fold decrease in the K(m) value for Prog reduction. We thus propose that Prog is maintained in a new steroid-binding site composed mainly of residues found in the carboxy-terminal region of the protein.

[1]  K. Bohren,et al.  The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity. , 1996, Biochemistry.

[2]  V. Luu‐The,et al.  Characterization of a human 20alpha-hydroxysteroid dehydrogenase. , 2000, Journal of molecular endocrinology.

[3]  J. Fontecilla-Camps,et al.  Unusual Charge Stabilization of NADP+ in 17β-Hydroxysteroid Dehydrogenase* , 1998, The Journal of Biological Chemistry.

[4]  P. K. Talwalker,et al.  Maintenance of Pregnancy in Spayed Rats with 20α-Hydroxypregn-4-ene-3-one and 20β-Hydroxypregn-4-ene-3-one , 1966, Nature.

[5]  Sheng-Xiang Lin,et al.  Crystallization and preliminary X-ray crystallographic analysis of the human type 3 3α-hydroxysteroid dehydrogenase at 1.8 Å resolution , 2001 .

[6]  T. Penning,et al.  The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase. , 1999, Biochemistry.

[7]  Lenton Ea,et al.  The endocrinology of conception cycles and implantation in women. , 1988 .

[8]  T. Penning,et al.  The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. , 1991, The Biochemical journal.

[9]  Haiching Ma,et al.  Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Palackal,et al.  Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. , 2001, Biochemistry.

[11]  D. Willey,et al.  Bacterial morphine dehydrogenase further defines a distinct superfamily of oxidoreductases with diverse functional activities. , 1994, The Biochemical journal.

[12]  Pierre Legrand,et al.  Structure of the Human 3α-Hydroxysteroid Dehydrogenase Type 3 in Complex with Testosterone and NADP at 1.25-Å Resolution* , 2001, The Journal of Biological Chemistry.

[13]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[14]  K. Sato,et al.  Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. , 1996, The Biochemical journal.

[15]  S. Paul,et al.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.

[16]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[17]  D. Poirier,et al.  Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: Oxidation/reduction and inhibition , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  M. Lewis,et al.  Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Michael E. Burczynski,et al.  Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .

[20]  T. Penning,et al.  Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. , 1998, Biochemistry.

[21]  Pierre Legrand,et al.  Expression, crystallization and preliminary X-ray analysis of human and rabbit 20alpha-hydroxysteroid dehydrogenases in complex with NADP(H) and various steroid substrates. , 2002, Acta crystallographica. Section D, Biological crystallography.

[22]  G. Petsko,et al.  Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. , 1994, Biochemistry.

[23]  M. J. Bennett,et al.  Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. , 1997, Structure.

[24]  Y. Sasaguri,et al.  Close kinship of human 20α‐hydroxysteroid dehydrogenase gene with three aldo‐keto reductase genes , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[25]  A. Hara,et al.  Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. , 1997, The Biochemical journal.

[26]  C. Lai,et al.  Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. , 1995, Biochemistry.

[27]  Short-chain dehydrogenases/reductases (SDR). , 1995 .

[28]  F. Labrie,et al.  Molecular Cloning of Human Type 3 3α-Hydroxysteroid Dehydrogenase That Differs from 20α-Hydroxysteroid Dehydrogenase by Seven Amino Acids , 1996 .

[29]  M Krook,et al.  Characteristics of short-chain alcohol dehydrogenases and related enzymes. , 1991, European journal of biochemistry.

[30]  Hans H. Zingg,et al.  Inhibition of oxytocin receptor function by direct binding of progesterone , 1998, Nature.

[31]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[32]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[33]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[34]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[35]  M. J. Bennett,et al.  Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+. , 1996, Biochemistry.

[36]  H. Shiraishi,et al.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes. , 1998, The Biochemical journal.

[37]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[38]  J. Fontecilla-Camps,et al.  The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. , 1996, Structure.

[39]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[40]  D. Farb,et al.  Dual activation of GABAA and glycine receptors by β-alanine : inverse modulation by progesterone and 5α-pregnan-3α-ol-20-one , 1993 .

[41]  J. Strauss,et al.  Induction of 20α-hydroxysteroid dehydrogenase in rat corpora lutea of pregnancy by prostaglandin F2α , 1974 .

[42]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[43]  D Bertrand,et al.  Progesterone modulates a neuronal nicotinic acetylcholine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. Labrie,et al.  Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1 , 2001 .

[45]  K. Tew,et al.  cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. , 1994, Biochimica et biophysica acta.

[46]  M. Nakanishi,et al.  Molecular cloning of two human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. , 1994, The Biochemical journal.

[47]  H. Takikawa,et al.  cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. , 1993, The Journal of biological chemistry.